2,918
Views
1
CrossRef citations to date
0
Altmetric
Methodology

Quantitative Bottom Up Analysis of Infliximab in Serum Using Protein A Purification and Integrated μLC-Electrospray Chip Ionkey MS/MS Technology

, , , &
Pages 891-904 | Received 30 Nov 2015, Accepted 07 Mar 2016, Published online: 12 Apr 2016

References

  • Ecker DM , JonesSD, LevineHL. The therapeutic monoclonal antibody market. MAbs7 (1), 9–14 (2015).
  • Reichert JM . Therapeutic monoclonal antibodies approved or in review in the European Union or the United States. Update 26 May2015. www.antibodysociety.org.
  • Danese S , ColombelJF, ReinischW, RutgeertsPJ. Review article: in?iximab for Crohn’s disease treatment shifting therapeutic strategies after 10 years of clinical experience. Aliment. Pharmacol. Ther. 33 (8), 857–869 (2011).
  • Stadlmann J . Applications of a Mass-spectrometric Method for the N-glycosylation Analysis of Immunoglobulin G molecules, in Department of Chemistry. University of Natural Resources and Applied Life Sciences, 31 (2009).
  • Damen CW , SchellensJH, BeijnenJH. Bioanalytical methods for the quantification of therapeutic monoclonal antibodies and their application in clinical pharmacokinetic studies. Hum. Antibodies18 (3), 47–73 (2009).
  • Schmitz EM , van de KerkhofD, HamannDet al. Therapeutic drug monitoring of infliximab: performance evaluation of three commercial ELISA kits. Clin. Chem. Lab. Med. doi: 10.1515/cclm-2015–0987 (2015) ( Epub ahead of print).
  • Van Den Broek I , NiessenWM, van DongenWD. Bioanalytical LC–MS/MS of protein based biopharmaceuticals. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 929, 161–179 (2013).
  • Jiang H , ZengJ, TitschCet al. Fully validated LC–MS/MS assay for the simultaneous quantitation of coadministered therapeutic antibodies in cynomolgus monkey serum. Anal. Chem. 85 (20), 9859–9867 (2013).
  • Jenkins R , DugganJX, AubryAFet al. Recommendations for validation of LC–MS/MS bioanalytical methods for protein biotherapeutics. AAPS J. 17 (1), 1–16 (2015).
  • Dufield D , NeubertH, GarofoloFet al. 2014 White paper on recent issues in bioanalysis: a full immersion in bioanalysis (Part 2 – hybrid LBA/LCMS, ELN & regulatory agencies’ input). Bioanalysis6 (23), 3237–3249 (2014).
  • Knutsson M , SchmidtR, TimmermanP. LC–MS/MS of large molecules in a regulated bioanalytical environment – which acceptance criteria to apply?Bioanalysis5 (18), 2211–2214 (2013).
  • Liu A , KozhichA, PassmoreDet al. Quantitative bioanalysis of antibody-conjugated payload in monkey plasma using a hybrid immuno-capture LC–MS/MS approach: Assay development, validation, and a case study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 1002, 54–62 (2015).
  • Willrich MA , MurrayDL, BarnidgeDR, LadwigPM, SnyderMR. Quantitation of infliximab using clonotypic peptides and selective reaction monitoring by LC–MS/MS. Int. Immunopharmacol. 28 (1), 513–520 (2015).
  • Kleinnijenhuis AJ , ToerscheJH, van HolthoonFL, BasRC, van DongenWD. A generic sample preparation approach for LC–MS/MS bioanalysis of therapeutic monoclonal antibodies in serum applied to infliximab. J. Appl. Bioanal. 1 (1), 26–34 (2015).
  • Peng X , LiuB, LiYet al. Development and validation of LC–MS/MS method for the quantitation of infliximab in human serum. Chromatographia78 (7–8), 521–531 (2015).
  • Gallagher R , DillonL, GrimsleyA, MurphyJ, SamuelssonK, DouceD. The application of a new microfluidic device for the simultaneous identification and quantitation of midazolam metabolites obtained from a single micro-litre of chimeric mice blood. Rapid Commun. Mass Spectrom. 28 (11), 1293–1302 (2014).
  • Alelyunas YW , RomanGT, JohnsonJ, DoneanuC, WronaMD. High throughput analysis at microscale: performance of ionKey/MS with Xevo G2-XS QTof under rapid gradient conditions. J. Appl. Bioanal. 1 (4), 128–135 (2015).
  • Broccardo CJ , SchauerKL, KohrtWM, SchwartzRS, MurphyJP, PrenniJE. Multiplexed analysis of steroid hormones in human serum using novel microflow tile technology and LC–MS/MS. J. Chromatogr. B934, 16–21 (2013).
  • Foster MW , ThompsonJW, LedfordJGet al. Identification and quantitation of coding variants and isoforms of pulmonary surfactant protein A. J. Proteome Res. 13 (8), 3722–3732 (2014).
  • Faria M , HalquistMS, YuanM, MylottWJr., KarnesRH. Comparison of a stable isotope labeled (SIL) peptide and an extended SIL peptide as internal standards to track digestion variability of an unstable signature peptide during quantification of a cancer biomarker, human osteopontin, from plasma using capillary microflow LC–MS/MS. J. Chromatogr. B1001, 156–168 (2015).
  • Waas M , BhattacharyaS, ChuppaSet al. Combine and conquer: surfactants, solvents, and chaotropes for robust mass spectrometry based analyses of membrane proteins. Anal. Chem. 86 (3), 1551–1559 (2014).
  • Hedrick VE , LaLandMN, NakayasuES, PaulLN. Digestion, purification, and enrichment of protein samples for mass spectrometry. Curr. Protoc. Chem. Biol. 7 (3), 201–222 (2015).
  • Leon IR , SchwämmleV, JensenON, SprengerRR. Quantitative assessment of in-solution digestion efficiency identifies optimal protocols for unbiased protein analysis. Mol. Cell Proteomics12 (10), 2992–3005 (2013).
  • Noga M , SucharskiF, SuderP, SilberringJ. A practical guide to nano-LC troubleshooting. J. Sep. Sci. 30 (14), 2179–2189 (2007).
  • Bergmann-Leitner ES , MeaseRM, DuncanEH, KhanF, WaitumbiJ, AngovE. Evaluation of immunoglobulin purification methods and their impact on quality and yield of antigen-specific antibodies. Malar. J. 7, 129 (2008).
  • Jansson B , UhlenM, NygrenPA. All individual domains of staphylococcal protein A show Fab binding. FEMS Immunol. Med. Microbiol. 20 (1), 69–78 (1998).
  • LSS Slope Calculator . http://hs2.proteome.ca/SSRCalc/Slope.
  • Spicer V , GrigoryanM, GotfridA, StandingKG, KrokhinOV. Predicting retention time shifts associated with variation of the gradient slope in peptide RP-HPLC. Anal. Chem. 82 (23), 9678–9685 (2010).
  • Vu H , SpicerV, GotfridA, KrokhinOV. A model for predicting slopes S in the basic equation for the linear-solvent-strength theory of peptide separation by reversed-phase high-performance liquid chromatography. J. Chromatogr. A1217, 489–497 (2010).
  • Gustavsson SÅ , SamskogJ, MarkidesKE, LångströmB. Studies of signal suppression in liquid chromatography-electrospray ionization mass spectrometry using volatile ion-pairing reagents. J. Chromatogr. A937, 41–47 (2001).
  • Jiang H , XuW, TitschCet al. Innovative use of LC–MS/MS for simultaneous quantitation of neutralizing antibody, residual drug, and human immunoglobulin G in immunogenicity assay development. Anal. Chem. 86 (5), 2673–2680 (2014).
  • Guidance for Industry Bioanalytical Method Validation . US Department of Health and Human Services, US FDA, Rockville, MD, USA (2001). www.fda.gov/downloads/Drugs/Guidances/ucm070107.pdf.
  • Guideline On Bioanalytical Method Validation . European Medicines Agency, London, UK (2011). www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500109686.pdf.